Vaxchora: payments to doctors
Payments that named Vaxchora as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $754K
- Providers
- 62
- Transactions
- 349
- Average per transaction
- $2,161
The per-transaction average — $2,161 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 62 providers the average total is $12,166, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Emergent Biosolutions Inc. | $753,004 | 99.8% |
| Bavarian Nordic A/s | $1,263 | 0.2% |